Cargando…

Transient compartment-like syndrome and normokalaemic periodic paralysis due to a Ca(v)1.1 mutation

We studied a two-generation family presenting with conditions that included progressive permanent weakness, myopathic myopathy, exercise-induced contracture before normokalaemic periodic paralysis or, if localized to the tibial anterior muscle group, transient compartment-like syndrome (painful acut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Chunxiang, Lehmann-Horn, Frank, Weber, Marc-André, Bednarz, Marcin, Groome, James R., Jonsson, Malin K. B., Jurkat-Rott, Karin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2013
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859226/ https://www.ncbi.nlm.nih.gov/pubmed/24240197 http://dx.doi.org/10.1093/brain/awt300

Ejemplares similares

Na(V)1.4 mutations cause hypokalaemic periodic paralysis by disrupting IIIS4 movement during recovery
por: Groome, James R., et al.
Publicado: (2014)

Domain III S4 in closed-state fast inactivation: Insights from a periodic paralysis mutation
por: Groome, James R, et al.
Publicado: (2014)

Kir2.2 p.Thr140Met: a genetic susceptibility to sporadic periodic paralysis
por: FAN, CHUNXIANG, et al.
Publicado: (2018)

Do Hyperpolarization-induced Proton Currents Contribute to the Pathogenesis of Hypokalemic Periodic Paralysis, a Voltage Sensor Channelopathy?
por: Jurkat-Rott, Karin, et al.
Publicado: (2007)

Rare KCNJ18 variants do not explain hypokalaemic periodic paralysis in 263 unrelated patients
por: Kuhn, Marius, et al.
Publicado: (2016)

Na(V)1.4 DI-S4 periodic paralysis mutation R222W enhances inactivation and promotes leak current to attenuate action potentials and depolarize muscle fibers
por: Bayless-Edwards, Landon, et al.
Publicado: (2018)

Successful treatment of periodic paralysis with coenzyme Q10: two case reports
por: Da, Yuwei, et al.
Publicado: (2016)

The impact of permanent muscle weakness on quality of life in periodic paralysis: a survey of 66 patients
por: CAVEL-GREANT, DEBORAH, et al.
Publicado: (2012)

Characterization of hyperkalemic periodic paralysis: a survey of genetically diagnosed individuals
por: Charles, G., et al.
Publicado: (2013)

Pathophysiological Role of Omega Pore Current in Channelopathies
por: Jurkat-Rott, Karin, et al.
Publicado: (2012)

I-10 Pathogenesis of muscle degeneration in periodic paralyses and DMD
por: Lehmann-Horn, F., et al.
Publicado: (2011)

A gating model for wildtype and R1448H Nav1.4 channels in paramyotonia
por: HOLZHERR, BORIS, et al.
Publicado: (2014)

State of the art in hereditary muscle channelopathies
por: Jurkat-Rott, K., et al.
Publicado: (2010)

A novel N440K sodium channel mutation causes myotonia with exercise-induced weakness - exclusion of CLCN1 exon deletion/duplication by MLPA
por: Lehmann-Horn, F., et al.
Publicado: (2011)

Eplerenone repolarizes muscle membrane through Na,K-ATPase activation by Tyr10 dephosphorylation
por: Breitenbach, Simon, et al.
Publicado: (2016)

Early-onset familial hemiplegic migraine due to a novel SCN1A mutation
por: Fan, Chunxiang, et al.
Publicado: (2016)

Sodium channelopathies of skeletal muscle result from gain or loss of function
por: Jurkat-Rott, Karin, et al.
Publicado: (2010)

The role of fibrosis in Duchenne muscular dystrophy
por: KLINGLER, WERNER, et al.
Publicado: (2012)

Rationale for treating oedema in Duchenne muscular dystrophy with eplerenone
por: LEHMANN-HORN, FRANK, et al.
Publicado: (2012)

Thyrotoxic Periodic Paralysis Associated with Transient Thyrotoxicosis Due to Painless Thyroiditis
por: Oh, Sang Bo, et al.
Publicado: (2012)

An atypical Ca(V)1.1 mutation reveals a common mechanism for hypokalemic periodic paralysis
por: Cannon, Stephen C.
Publicado: (2017)

ClC1 chloride channel in myotonic dystrophy type 2 and ClC1 splicing in vitro
por: URSU, SIMONA-FELICIA, et al.
Publicado: (2012)

Hypermetabolism in B–lymphocytes from malignant hyperthermia susceptible individuals
por: Hoppe, Kerstin, et al.
Publicado: (2016)

A role for external Ca(2+) in maintaining muscle contractility in periodic paralysis
por: Cannon, Stephen C.
Publicado: (2020)

Thyrotoxic periodic paralysis
por: Balakrishnan, Rojith Karanode, et al.
Publicado: (2011)

Hypokalemic periodic paralysis
por: Abbas, Haider, et al.
Publicado: (2012)

Familial Periodic Paralysis
por: Khan, Mohd. Yousaf
Publicado: (1935)

Thyrotoxic Periodic Paralysis
por: Seetharaman, Kavita
Publicado: (2021)

Sporadic adult‐onset brainstem hyperkalemic periodic paralysis masquerading as recurrent transient ischemic attacks
por: Liang, Kathryn M.A., et al.
Publicado: (2022)

Transient paralysis after robotic prostatectomy
por: Deem, Samuel, et al.
Publicado: (2008)

Paxilline Prevents the Onset of Myotonic Stiffness in Pharmacologically Induced Myotonia: A Preclinical Investigation
por: Hoppe, Kerstin, et al.
Publicado: (2020)

(23)Na MRI and myometry to compare eplerenone vs. glucocorticoid treatment in Duchenne dystrophy
por: A. Glemser, Philip, et al.
Publicado: (2017)

Thyrotoxic periodic paralysis: a rare cause of periodic paralysis – a case report
por: Poudel, Rajendra, et al.
Publicado: (2023)

Hypokalemic periodic paralysis due to CACNA1S gene mutation
por: Alhasan, Khalid A., et al.
Publicado: (2019)

Hyperthyroid hypokalemic periodic paralysis
por: Neki, N.S.
Publicado: (2016)

Thyrotoxic Hypokalemic Periodic Paralysis
por: Sonkar, Satyendra Kumar, et al.
Publicado: (2018)

Thyrotoxic periodic paralysis: an overview
por: Hsieh, Chang-Hsun, et al.
Publicado: (2004)

Comparative study of thyrotoxic periodic paralysis from idiopathic hypokalemic periodic paralysis: An experience from India
por: Kalita, J., et al.
Publicado: (2012)

Atypical periodic paralysis and myalgia: A novel RYR1 phenotype
por: Matthews, Emma, et al.
Publicado: (2018)

Relevance of pathogenicity prediction tools in human RYR1 variants of unknown significance
por: Hoppe, Kerstin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rqm58ecv77nujmmo1qdu9a4ho1